The novel treatment of this peptide represents a significant advance in the handling of type 2 diabetes. Distinct from existing therapies, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide713276.blogzag.com/85391247/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment